Difference between revisions of "Part:BBa K4225014"
Line 7: | Line 7: | ||
and an Inhibitory Sequence (BBa_K4225013). For the experiment result of the characterization of this part, refer to the composite part [https://parts.igem.org/Part:BBa_K4225019 BBa_K4225019.] | and an Inhibitory Sequence (BBa_K4225013). For the experiment result of the characterization of this part, refer to the composite part [https://parts.igem.org/Part:BBa_K4225019 BBa_K4225019.] | ||
− | + | For teams that are planning to use the sequence, please remove the TAATAA sequence at the end of the LVA tag | |
<!-- Add more about the biology of this part here | <!-- Add more about the biology of this part here | ||
===Usage and Biology=== | ===Usage and Biology=== |
Latest revision as of 05:57, 11 October 2022
LVA-CS-IS, LVA tag with an inhibitory sequence at C-terminal to prevent recognition of LVA tag
This is a composite part that consist of 3 basic parts, LVA tag (BBa_K880004), TEV protease cleave site (BBa_K1319016)
and an Inhibitory Sequence (BBa_K4225013). For the experiment result of the characterization of this part, refer to the composite part BBa_K4225019.
For teams that are planning to use the sequence, please remove the TAATAA sequence at the end of the LVA tag Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000INCOMPATIBLE WITH RFC[1000]Illegal SapI site found at 59